GlucoGuard Receives $43 Million Enterprise Valuation Research Report
Del Mar, California--(Newsfile Corp. - June 10, 2025) - Harbinger Research, LLC an independent equity research firm with a focus on the small cap and microcap stocks, announced today that it has published a new research report on American Diversified Holdings Corporation/GlucoGuard (OTC Pink: ADHC).
The report includes a valuation analysis, multi-year financial forecast model, and a value estimate of the Company and its shares. The report puts a fully diluted price target of .0012 equivalent to a $43 million enterprise valuation, assuming full dilution for required developmental capital at the current stock price. As the stock price increases, the dilution would decline accordingly raising the price target. Currently, ADHC is working with Investment Partners on Capital Formation that will benefit the enterprise valuation model utilizing non-dilutive or controlled dilutive financial models.
As the development process continues further Intellectual Property filings with the USPTO is anticipated further enhancing GlucoGuards' valuation proposition.
A main catalyst for GlucoGuards valuation will be fully described in future releases with a full analysis of the artificial intelligence and predictive learning aspect of the Bio Tracking and recording of blood Glucose levels.
To access the research report, please visit the Harbinger Research website at:
2023-06-02 American Diversified Holdings Corp. Coverage Initiation Report (d1io3yog0oux5.cloudfront.net)
"Management views the $43 M enterprise value to be conservative due to ability of the GlucoGuard technology to meet the unmet need of hypoglycemia and the severe problems of "Death in Bed"," commented ADHC. "Additionally, this report does not incorporate GlucoGuards' AI and Predictive learning software components and related IP due to its developing nature," concluded ADHC.
Key Aspects of the Report
537mm Diabetic Patients Worldwide.
37 mm Diabetic Patients In the US.
3.7 Type 1 Diabetics in the US.
190k to 380K Potential Patients in the US.
a potential market of $360 MM to $720MM in revenues.
IN ADDITIONAL NEWS
ADHC is in negotiations for a strategic partnership to license the GlucoGuard Technology to the Eurpean Union for upfront cash payments, milestone cash payments and cash payment royalties from revenues.
Arete Biosciences development contract has been initially funded and is expected to expand into patient studies.
ADHC 6-15-25 Quartely disclosure filing is expected to be filed this week ahead of the deadline.
Dexcom APP integration and AI software system is under review and should be proceeding to the next phase in the near term.
Patent Counsel is updating GlucoGuards' IP with the USPTO.
Shareholders should anticipate and continual stream of announcements on these developments and more in the near future.
About Harbinger Research, LLC
Harbinger Research, LLC is one of a new breed of issuer-sponsored research boutiques, providing unbiased equity research coverage to smaller issuers that cannot attract research coverage from traditional brokerage firm's research departments. Our mission is to help both investors and public issuers by improving the availability of issuer information and by providing sound, unbiased analysis of our issuer clients' businesses, industries, and current market valuation.
The policies of Harbinger Research, LLC require that all personnel strictly adhere to the CFA Institute's Code of Ethics and Standards of Professional Conduct, and its Best Practice Guidelines Governing Analyst / Corporate Issuer Relations. Please see www.cfainstitute.org for more information.
To view our disclosures and disclaimers, or for more information, visit www.harbingerresearch.com.
Harbinger Research, LLC Brian Connell, CFA Senior Research Analyst brian@harbingerresearch.com.
GlucoGuard, a Division of American Diversified Holdings Corporation is a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. The system helps prevent the dangerous effects of low blood sugar during sleep, including the potentially fatal "Death in Bed" phenomenon. Collaborating with a leading U.S. research university, a prominent biomedical engineering firm, and a major CGM company, GlucoGuard is at the forefront of diabetes management technology.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/255016_6d0a10f01418bade_001full.jpg
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/254131_81935201249818a5_002full.jpg
ABOUT AMERICAN DIVERSIFIED HOLDINGS CORPORATION
John Cacchioli, CEO
American Diversified Holdings Corporation
Telephone: (212) 537-5900
INVESTOR HOTLINE 858-325-7098
Email: JC@American-Diversified.com; ADHCInvestor@Yahoo.com
SOCIAL MEDIA
TWITTER: @ADHCManagement.
This Twitter page is the only official Twitter page for ADHC.
SAFE HARBOR FORWARD-LOOKING STATEMENTS: This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
29 minutes ago
- Globe and Mail
AMD, INTC, or NVDA: Which Chip Stock Is Wall Street's Best Pick?
Easing chip restrictions and trade negotiations have improved the sentiment for chip stocks, though worries about macro uncertainty and increased competition continue to be an overhang. Nonetheless, Wall Street remains bullish on some chip stocks, mainly due to robust demand for advanced chips to support the ongoing AI (artificial intelligence) boom. Using TipRanks' Stock Comparison Tool, we placed Advanced Micro Devices (AMD), Intel (INTC), and Nvidia (NVDA) against each other to find the best chip stock, according to Wall Street analysts. Confident Investing Starts Here: Advanced Micro Devices (NASDAQ:AMD) Advanced Micro Devices stock has advanced 4% in the past month due to favorable news on chip export restrictions and tariffs. However, AMD stock is still down 3.5% year-to-date, as worries about macro woes and the company lagging the AI race continue to weigh on market sentiment. Last month, AMD impressed investors with its upbeat first-quarter results, strong performance of the data center segment, and solid guidance. However, investors continue to await more aggressive growth in the AI space. At the Advancing AI event held on June 12, AMD CEO Lisa Su spoke about the company's MI350 series and MI400 series AI chips, which are expected to compete with Nvidia's Blackwell processors. Further, the MI400 series of chips will be the basis for AMD's new server called Helios, which the company plans to release next year to compete with Nvidia's NVL72 servers. However, the much-anticipated Advancing AI event failed to move AMD stock higher, as the chips discussed at the event might not immediately change the company's competitive position. Is AMD Stock a Buy or Sell Now? Following the Advancing AI event, Baird analyst Tristan Gerra reiterated a Buy rating on AMD stock with a price target of $140. The 4-star analyst noted that AMD raised its AI accelerator total addressable market (TAM) estimate to more than $500 billion by 2028, up from the prior estimate of $500 billion, representing over 60% compound annual growth rate (CAGR). The company expects the inferencing market to grow by above an 80% CAGR during this time. The analyst noted the products showcased by the company, including the MI350 series, MI355x, and the Helios AI rack. He also mentioned the AMD Developer Cloud, which will provide users access to a fully managed cloud environment. Overall, Wall Street has a Moderate Buy consensus rating on Advanced Micro Devices stock based on 22 Buys and 10 Holds. The average AMD stock price target of $127.93 indicates about 8% upside potential. See more AMD analyst ratings Intel (NASDAQ:INTC) Chipmaker Intel has been struggling in recent years due to the continued loss of share in the CPU market to AMD, a lack of innovation, strategic missteps, persistent delays in product launches, and instability in the management team. While Intel CEO Lip-Bu Tan is trying to revive the business by improving efficiency, reducing costs, and launching new products, several analysts remain cautious on Intel due to the uncertainty about its turnaround, given the company's unimpressive performance and poor execution in recent years. Also, investors are increasingly concerned about Intel losing the opportunity to capture the massive demand for advanced chips needed in AI models. Is Intel Stock a Buy or Sell? Recently, Deutsche Bank analyst Ross Seymore initiated coverage of Intel stock with a Hold rating and price target of $23. The 5-star analyst believes that despite the turnaround efforts, investors will still have to show patience, as Intel navigates macro uncertainties and company-specific headwinds related to high manufacturing costs and a lack of leading products. While Seymore has confidence in Tan's leadership and the higher odds of a successful turnaround under his guidance, he pointed out the absence of formal details of his strategic vision. Seymore believes that the road to Intel generating notable EPS/free cash flow remains unclear and highly dependent on a turnaround in the foundry business, which he contends is 'no small feat.' He expects Intel to deliver EPS of about $2 by 2027 if the company successfully restructures its manufacturing processes, product roadmap, and customer wins in the foundry business. Turning to Wall Street, Intel stock has a Hold consensus rating based on one Buy, 26 Holds, and four Sell ratings. The average INTC stock price target of $21.30 implies a modest upside of 2.5%. Intel stock has risen just 1.4% so far in 2025. See more INTC analyst ratings Nvidia (NASDAQ:NVDA) After struggling earlier in the year, Nvidia stock has risen about 10% over the past month, bringing the year-to-date gains to 6.4%. The company addressed investors' concerns with its market-beating results for the first quarter of Fiscal 2026. Moreover, easing chip export restrictions and favorable agreements that eased trade war tensions helped improve investor sentiment. Meanwhile, Nvidia continues to announce major deals that reflect robust demand for the company's GPUs (graphics processing units) that are required for AI workloads. Notably, the company is focusing on international expansion to capture solid AI opportunities. This week, Nvidia announced multiple partnerships with European countries and companies, under which it would offer AI infrastructure and software solutions. One of the notable partnerships is with French startup Mistral. Under this deal, the French company will build an AI cloud that will deploy 18,000 Nvidia Grace Blackwell chips, allowing businesses to develop and use AI via Mistral's models. Is NVDA Stock a Buy Right Now? Following Nvidia's GTC event in Paris, France, UBS analyst Timothy Arcuri reiterated a Buy rating with a price target of $175. The analyst stated that the Paris event reinforced that NVDA's 'demand funnel' is expanding from a handful of U.S. hyperscalers to sovereign states and brownfield industries, creating the possibility of upward revisions to estimates. Arcuri noted that Nvidia now has a line of sight to about $1.5 trillion of AI infrastructure investment over the next several years, consistent with the company's prior commentary on a pipeline of 'tens of gigawatts' of projects within a 2 to 3 year timeframe and $40 to $50 billion of revenue per gigawatt of AI data center capacity. This, according to Arcuri, indicates Nvidia's data center revenue in the range of $400 billion per year or about 2x his $233 billion estimate for calendar year 2026. He believes that such impressive estimates should address investors' concerns around a near – or even medium-term EPS peak. With 35 Buys, four Holds, and one Sell recommendation, Wall Street has a Strong Buy consensus rating on Nvidia stock. At $172.36, the average NVDA stock price target implies about 19% upside potential. Conclusion Wall Street is sidelined on Intel stock, modestly bullish on AMD stock, and highly optimistic on Nvidia stock. Analysts see higher upside potential in Nvidia stock than in the other two chip stocks. Wall Street sees continued strength in Nvidia's business, driven by its innovation, solid execution, and the demand for its advanced offerings in the ongoing AI wave.
Globe and Mail
3 hours ago
- Globe and Mail
Warren Buffett Says to Buy This Vanguard ETF. It Could Turn $1,000 Per Month Into $245,000 in 10 Years.
Top fund managers consistently select individual stocks to build high-performing portfolios. While individual investors often believe they can do the same, and some actually might, the vast majority of people aren't as skilled at stock selection. Here's where the recommendation of Warren Buffett comes into play. The Oracle of Omaha suggests the right course of action for most people is to simply invest their money in a low-cost index fund, particularly one that tracks the performance of the broad market S&P 500 index. One exchange-traded fund (ETF) of this type that comes to mind is the Vanguard S&P 500 ETF (NYSEMKT: VOO). Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Investors who choose this path and follow it consistently put themselves in a position to be rewarded over time. For example, investing just $1,000 per month in this ETF could result in a portfolio balance of $245,000 in 10 years. Here's what you need to know. Using history as a guide to the future In the past decade, the Vanguard S&P 500 ETF has produced a total return of 244%, with dividends reinvested. That's a fantastic outcome, likely buoyed by huge capital inflows into passive investment options over active strategies, generally solid economic growth, and the rise of several dominant tech enterprises. That trailing 10-year gain puts its compound annual growth rate at about 13% -- well ahead of the market's long-run average of 10% annually. For the sake of this article, let's assume that the next 10 years will resemble the last decade when it comes to returns. Of course, nothing is guaranteed, and the future is inherently unpredictable. But if you invest $1,000 per month between now and 2035 (for a total of 120 investments), you'd have around $245,000 in a decade. This is the power of dollar-cost averaging. You might think that to succeed as an investor, you have to make decisions like a pro and try to correctly time the market. The intention of buying low, selling high, and repeating the process sounds good in theory. However, it's virtually impossible to do well on a consistent basis. That's why a dollar-cost averaging approach makes the most sense: If you add more money to your portfolio consistently at regular intervals, you can be assured that you're taking advantage of the inevitable ups and downs of the market. Other benefits of this winning strategy Knowing that $1,000 per month can end up becoming $245,000 should be enough to get any investor excited about putting money to work in the stock market. There are other clear benefits to adopting this no-brainer strategy. For one, there's a strong chance the portfolio will beat a majority of the experts. Data shows that the performances of most actively managed funds lag the S&P 500 over long stretches of time. This doesn't prevent fund managers from charging high fees that further eat away at the returns of their investors. The Vanguard S&P 500 ETF, on the other hand, has an expense ratio of just 0.03%. That's a charge of $3 a year for every $10,000 a person has invested in the fund. That's hard to beat. Another benefit is that this is a hassle-free approach. Investors don't need fancy degrees or certifications, expert financial analysis skills, or hours of free time every week to listen to earnings calls. Putting money into the Vanguard S&P 500 ETF on a monthly basis is essentially an automatic investment allocation. It couldn't be simpler. It instantly provides investors with broad diversification into 500 of the largest U.S. companies. The ETF has exposure to all sectors, from technology and financial services businesses to energy and utilities. It's a bet on the growth of the American economy and on the premise that it will continue doing what it has always done. This seems like a smart bet to make. Buying $1,000 worth of the Vanguard S&P 500 ETF every month should put you on the path to building your wealth in the next decade and beyond. Should you invest $1,000 in Vanguard S&P 500 ETF right now? Before you buy stock in Vanguard S&P 500 ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard S&P 500 ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor 's total average return is988% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
3 hours ago
- Globe and Mail
Foxconn Exports 97% of India-Made iPhones to U.S. to Avert China Tariffs
Apple's (AAPL) largest supplier Foxconn has ramped up exports of India-made iPhones to the U.S. to avoid the hefty tariffs on Chinese goods. According to a Reuters report citing official customs data, an average of 97% of iPhones produced in India were shipped to the U.S. between March and May. The data shows a stark jump in exports of Indian iPhones compared to the 50% monthly average recorded in 2024. India faces a baseline 10% tariff, while Trump has proposed a revised 55% tariff on Chinese imports following the U.S.-China trade deal. Confident Investing Starts Here: China has been the primary manufacturing hub for iPhones, with roughly 80% of U.S.-bound iPhones amounting to about 60 million units annually, originating from the mainland. The sharp redirection of orders to India highlights Apple's determination in skirting the hefty tariffs imposed by the U.S. government on Chinese goods. President Donald Trump aims to bolster America's manufacturing industries by implementing these tariffs, but large corporations are clearly finding alternative solutions to circumvent them. China Strengthens Its Strategy on India-Made iPhones Apple has manufacturing bases in several countries, including the Netherlands, Britain, and the Czech Republic. However, the company has recently grown increasingly dependent on India's manufacturing expertise. Despite several warnings from Trump to stop producing iPhones in India, CEO Tim Cook seems to be happily ignoring them. The company is said to have made special arrangements at the Chennai airport in Tamil Nadu state, its key iPhone export hub, to shorten customs clearance time from 30 hours to just six hours. Between March and May 2025, Foxconn exported iPhones worth $3.2 billion from India, with a majority destined for the U.S. market. In May alone, India exported $1 billion worth of iPhones to the U.S., following a record $1.3 billion in March. Notably, in the first five months of this year, Foxconn has already shipped India-made iPhones worth $4.4 billion to the U.S., compared to exports of $3.7 billion for the whole of 2024. In March, Apple sent six special chartered flights from India to the U.S., exporting the bulk of iPhones 13, 14, 16 and 16e models worth roughly $2 billion, just before Trump's global tariffs were expected to take effect. Apple's other Indian supplier, Tata Electronics, also exported 86% of its March and April iPhone production to the U.S., a significant increase from the 52% average recorded last year. Although India is promoting itself as a smartphone manufacturing hub, it still incurs high import duties on certain components, making manufacturing more expensive in India compared to Vietnam and Mexico. Is Apple a Good Stock to Buy Now? Analysts remain divided on Apple's long-term stock trajectory due to ongoing tariff-related uncertainty. On TipRanks, AAPL stock has a Moderate Buy consensus rating based on 16 Buys, nine Holds, and four Sell ratings. Also, the average Apple price target of $226.94 implies 13.9% upside potential from current levels. Year-to-date, AAPL stock has lost 20.3%. See more AAPL analyst ratings
